1
Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
Condition(s):Ventricular Premature Complexes; Myocardial IschemiaLast Updated:January 29, 2020Completed
Ranolazine as an Intervention: 87 Clinical Trials, Page 1 of 9
Hide Studies Not Open or Pending
2
Study to Reduce Symptoms of Premature Beats With Ranolazine
Condition(s):Premature Ventricular BeatsLast Updated:May 1, 2015Unknown status
3
Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
Condition(s):Myotonia Congenita; Paramyotonia Congenita; Myotonic Dystrophy 1Last Updated:March 5, 2019Completed
4
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
Condition(s):CardiomyopathyLast Updated:February 18, 2020Terminated
5
Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
Condition(s):Pulmonary Hypertension; Diastolic Left Ventricular DysfunctionLast Updated:May 17, 2017Completed
6
Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)
Condition(s):Chronic Stable AnginaLast Updated:April 3, 2018Unknown status
7
Ranolazine, Ethnicity and the Metabolic Syndrome
Condition(s):Coronary Artery Disease; Angina; Metabolic SyndromeLast Updated:July 11, 2013Unknown status
8
Ranolazine for the Treatment of Chest Pain in HCM Patients
Condition(s):Hypertrophic CardiomyopathyLast Updated:March 3, 2017Completed
9
Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)
Condition(s):Microvascular AnginaLast Updated:May 21, 2019Completed
10
Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia
Condition(s):Coronary Artery Disease; Acute Myocardial IschemiaLast Updated:January 12, 2018Completed